• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ST 段压低的消退:ST 段抬高型心肌梗死的一个新的预后标志物。

Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.

机构信息

Department of Medicine, University of Alberta, Edmonton, Canada.

出版信息

Eur Heart J. 2010 Mar;31(5):573-81. doi: 10.1093/eurheartj/ehp494. Epub 2009 Dec 1.

DOI:10.1093/eurheartj/ehp494
PMID:19952006
Abstract

AIMS

To evaluate the prognostic impact of ST depression resolution among patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary PCI in the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.

METHODS AND RESULTS

In this study, 4729 of 5745 patients had analysable ECGs demonstrating concomitant ST-segment depression. Resolution of summation operatorST elevation (STE-R) and summation operatorST depression (STD-R) on 30 min post-PCI ECGs was dichotomized into those with > or =50 vs. <50% ST-segment resolution. Overall, 1143 patients (24%) had STD-R<50%. These patients had higher risk characteristics including older age, female sex, diabetes, hypertension, prior CHF/MI, Killip class >I, triple vessel disease, and less frequent TIMI 3 flow in the culprit coronary vessel post-PCI. After multivariable adjustment and accounting for STE-R, STD-R<50% remained an independent predictor for 90 day death and the composite of death, cardiogenic shock, or CHF. When compared with patients with both STE-R and STD-R> or =50%, patients with both STE-R and STD-R<50% had the worst outcomes [hazard ratios (HR) 90 day death: 2.54; 95% confidence intervals (CI): 1.71-3.77; HR 90 day composite: 2.18; 95% CI: 1.63-2.91].

CONCLUSION

When ST depression is present in STEMI patients undergoing primary PCI, STD-R<50% provides independent prognostic value that is incremental to STE-R.

摘要

目的

评估在接受直接经皮冠状动脉介入治疗(PCI)的 ST 段抬高型心肌梗死(STEMI)患者中,ST 段压低消退的预后影响,该研究为评估 Pexelizumab 在急性心肌梗死中的作用(APEX-AMI)试验。

方法和结果

在这项研究中,5745 例患者中有 4729 例可分析心电图,显示并发 ST 段压低。PCI 后 30 分钟心电图上的总和算子 ST 段抬高(STE-R)和总和算子 ST 段压低(STD-R)的消退被分为>或=50%与<50% ST 段消退。总体而言,1143 例患者(24%)有 STD-R<50%。这些患者具有更高的风险特征,包括年龄较大、女性、糖尿病、高血压、既往心力衰竭/心肌梗死、Killip 分级>I、三支血管病变以及 PCI 后罪犯血管中 TIMI 3 级血流较少。在多变量调整后,考虑到 STE-R,STD-R<50%仍然是 90 天死亡和死亡、心源性休克或心力衰竭复合终点的独立预测因素。与 STE-R 和 STD-R>或=50%的患者相比,STE-R 和 STD-R 均<50%的患者的预后最差[90 天死亡的危险比(HR):2.54;95%置信区间(CI):1.71-3.77;90 天复合终点的 HR:2.18;95%CI:1.63-2.91]。

结论

在接受直接 PCI 的 STEMI 患者中,如果存在 ST 段压低,STD-R<50%提供了与 STE-R 相比具有独立预后价值的信息。

相似文献

1
Resolution of ST-segment depression: A new prognostic marker in ST-segment elevation myocardial infarction.ST 段压低的消退:ST 段抬高型心肌梗死的一个新的预后标志物。
Eur Heart J. 2010 Mar;31(5):573-81. doi: 10.1093/eurheartj/ehp494. Epub 2009 Dec 1.
2
A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.急性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后死亡率的预测模型:来自 Pexelizumab 在急性心肌梗死试验中的评估结果。
Circ Cardiovasc Interv. 2010 Oct;3(5):414-22. doi: 10.1161/CIRCINTERVENTIONS.109.925180. Epub 2010 Sep 21.
3
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后的ST段恢复情况及预后:急性心肌梗死中佩昔单抗评估(APEX-AMI)试验的见解
Circulation. 2008 Sep 23;118(13):1335-46. doi: 10.1161/CIRCULATIONAHA.108.767772. Epub 2008 Sep 8.
4
Is visual interpretation of coronary epicardial flow reliable in patients with ST-elevation myocardial infarction undergoing primary angioplasty? Insights from the angiographic substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.在接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者中,冠状动脉心外膜血流的目测评估是否可靠?来自 Pexelizumab 在急性心肌梗死评估(APEX-AMI)试验的血管造影亚研究的结果。
Am Heart J. 2010 May;159(5):899-904. doi: 10.1016/j.ahj.2010.02.028.
5
Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.QRS 评分作为 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗后出院的强预后标志物的效用。
Am J Cardiol. 2010 Sep 1;106(5):630-4. doi: 10.1016/j.amjcard.2010.04.013.
6
Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".ST 段抬高型心肌梗死经皮冠状动脉介入治疗后的心原性休克和心力衰竭:来自“Pexelizumab 在急性心肌梗死中评估”的观察结果。
Am Heart J. 2011 Jul;162(1):89-97. doi: 10.1016/j.ahj.2011.04.009.
7
[Rapid resolution of ST segment elevation predicts recovery of left myocardial contraction in patients with acute myocardial infarction treated with percutaneous coronary angioplasty].[ST段抬高的快速恢复预示接受经皮冠状动脉介入治疗的急性心肌梗死患者左心室心肌收缩功能的恢复]
Przegl Lek. 2002;59(8):638-41.
8
Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.预测 ST 段抬高型心肌梗死 90 天后的慢性左心室功能障碍:pexelizumab 在急性心肌梗死中的评估(APEX-AMI)亚研究。
Am Heart J. 2010 Aug;160(2):272-8. doi: 10.1016/j.ahj.2010.05.035.
9
Comparison of prognostic value of epicardial blood flow and early ST-segment resolution after primary coronary angioplasty. ANIN--Myocardial Infarction Registry.直接冠状动脉血管成形术后心外膜血流与早期ST段恢复的预后价值比较。ANIN——心肌梗死登记处。
Kardiol Pol. 2007 Jan;65(1):1-10; discussion 11-2.
10
Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.直接经皮冠状动脉介入治疗 ST 段抬高型心肌梗死患者左心室舒张末期压的预后意义:来自急性心肌梗死中佩尔izumab评估研究的结果。
Am Heart J. 2013 Nov;166(5):913-9. doi: 10.1016/j.ahj.2013.08.006. Epub 2013 Sep 24.

引用本文的文献

1
Defective recovery of QT dispersion due to no-reflow following acute interventional therapy in patients with ST-segment elevation myocardial infarction.ST段抬高型心肌梗死患者急性介入治疗后无复流导致QT离散度恢复不良。
Cardiovasc Diagn Ther. 2024 Jun 30;14(3):388-401. doi: 10.21037/cdt-23-398. Epub 2024 Jun 18.
2
"No-Reflow" Phenomenon: A Contemporary Review.“无复流”现象:当代综述
J Clin Med. 2022 Apr 16;11(8):2233. doi: 10.3390/jcm11082233.
3
Predictors of ST Depression Resolution in STEMI Patients Undergoing Primary PCI and Its Clinical Significance.
接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者ST段压低恢复的预测因素及其临床意义。
Int J Gen Med. 2020 Jun 8;13:271-279. doi: 10.2147/IJGM.S258573. eCollection 2020.
4
ST-segment depression in left precordial leads in electrocardiogram of patients with acute inferior myocardial infarction undergoing primary percutaneous coronary intervention.接受直接经皮冠状动脉介入治疗的急性下壁心肌梗死患者心电图中左胸前导联ST段压低。
Interv Med Appl Sci. 2018 Dec;10(4):191-197. doi: 10.1556/1646.10.2018.19.
5
Tpeak-Tend/QT interval predicts ST-segment resolution and major adverse cardiac events in acute ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention.Tpeak-Tend/QT间期可预测接受经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者的ST段恢复情况及主要不良心脏事件。
Medicine (Baltimore). 2018 Oct;97(43):e12943. doi: 10.1097/MD.0000000000012943.
6
Importance of Endogenous Fibrinolysis in Platelet Thrombus Formation.内源性纤维蛋白溶解在血小板血栓形成中的重要性。
Int J Mol Sci. 2017 Aug 25;18(9):1850. doi: 10.3390/ijms18091850.
7
New ST-depression: an under-recognized high-risk category of 'complete' ST-resolution after reperfusion therapy.新的 ST 段压低:再灌注治疗后“完全”ST 段回落中被低估的高危类别。
Eur Heart J Acute Cardiovasc Care. 2012 Sep;1(3):210-21. doi: 10.1177/2048872612454841.